Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer to Distribute Sebia Newborn Screening System

NEW YORK (GenomeWeb) – PerkinElmer has signed an agreement to serve as the exclusive global distributor for Sebia's Capillarys 2 Neonat Fast system for labs conducting newborn screening.

The capillary electrophoresis system enables fully automated hemoglobin newborn screening from dried blood spot samples. It is used to test for hemoglobinopathies, such as sickle cell disease.

"Sebia's offering complements our hemoglobin screening portfolio by providing laboratories with an automated option, which can help them obtain clinically actionable information and insights to achieve better outcomes," Prahlad Singh, president of diagnostics at PerkinElmer, said in a statement.

Terms of the agreement weren't disclosed.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.